240 related articles for article (PubMed ID: 27919874)
1. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
Hines MC; Reed BN; Ivaturi V; Bontempo LJ; Bond MC; Hayes BD
Am J Health Syst Pharm; 2016 Dec; 73(24):2068-2076. PubMed ID: 27919874
[TBL] [Abstract][Full Text] [Related]
2. Achieving ventricular rate control in patients taking chronic beta-blocker therapy.
Feeney ME; Rowe SLB; Mah ND; Barton CA; Ran R
Am J Emerg Med; 2018 Jan; 36(1):110-113. PubMed ID: 29055615
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic comparison of intravenous push diltiazem versus metoprolol for atrial fibrillation rate control.
Nicholson J; Czosnowski Q; Flack T; Pang PS; Billups K
Am J Emerg Med; 2020 Sep; 38(9):1879-1883. PubMed ID: 32745920
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sustained rate control in atrial fibrillation with rapid ventricular rate: Metoprolol vs. Diltiazem.
Hargrove KL; Robinson EE; Lusk KA; Hughes DW; Neff LA; Fowler AL
Am J Emerg Med; 2021 Feb; 40():15-19. PubMed ID: 33338675
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
Fromm C; Suau SJ; Cohen V; Likourezos A; Jellinek-Cohen S; Rose J; Marshall J
J Emerg Med; 2015 Aug; 49(2):175-82. PubMed ID: 25913166
[TBL] [Abstract][Full Text] [Related]
6. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
Hasbrouck M; Nguyen TT
Am J Emerg Med; 2022 Aug; 58():39-42. PubMed ID: 35623182
[TBL] [Abstract][Full Text] [Related]
7. Achieving ventricular rate control using metoprolol in β-blocker-naive patients vs patients on chronic β-blocker therapy.
Kuang P; Mah ND; Barton CA; Miura AJ; Tanas LR; Ran R
Am J Emerg Med; 2016 Mar; 34(3):606-8. PubMed ID: 26830391
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction.
Hirschy R; Ackerbauer KA; Peksa GD; O'Donnell EP; DeMott JM
Am J Emerg Med; 2019 Jan; 37(1):80-84. PubMed ID: 29731345
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness.
Scheuermeyer FX; Grafstein E; Stenstrom R; Christenson J; Heslop C; Heilbron B; McGrath L; Innes G
Acad Emerg Med; 2013 Mar; 20(3):222-30. PubMed ID: 23517253
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Weight-Based Dose vs. Standard Dose Diltiazem in Patients with Atrial Fibrillation Presenting to the Emergency Department.
Ross AL; O'Sullivan DM; Drescher MJ; Krawczynski MA
J Emerg Med; 2016 Oct; 51(4):440-446. PubMed ID: 27452987
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Eur Heart J; 2014 Feb; 35(8):517-24. PubMed ID: 24135831
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation.
Demircan C; Cikriklar HI; Engindeniz Z; Cebicci H; Atar N; Guler V; Unlu EO; Ozdemir B
Emerg Med J; 2005 Jun; 22(6):411-4. PubMed ID: 15911947
[TBL] [Abstract][Full Text] [Related]
13. Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation.
Personett HA; Smoot DL; Stollings JL; Sawyer M; Oyen LJ
Ann Pharmacother; 2014 Mar; 48(3):314-9. PubMed ID: 24408816
[TBL] [Abstract][Full Text] [Related]
14. Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis.
Lan Q; Wu F; Han B; Ma L; Han J; Yao Y
Am J Emerg Med; 2022 Jan; 51():248-256. PubMed ID: 34781150
[TBL] [Abstract][Full Text] [Related]
15. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
Atzema CL; Austin PC
Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
[TBL] [Abstract][Full Text] [Related]
16. Intravenous metoprolol versus diltiazem for atrial fibrillation with concomitant heart failure.
Compagner CT; Wysocki CR; Reich EK; Zimmerman LH; Holzhausen JM
Am J Emerg Med; 2022 Dec; 62():49-54. PubMed ID: 36252310
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate.
Nuñez Cruz S; DeMott JM; Peksa GD; Slocum GW
Am J Emerg Med; 2021 Aug; 46():329-334. PubMed ID: 33092938
[TBL] [Abstract][Full Text] [Related]
18. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation.
Xiao SQ; Ibarra F; Cruz M
Ann Pharmacother; 2022 Aug; 56(8):916-921. PubMed ID: 34738470
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of metoprolol versus diltiazem for rate control of atrial fibrillation in the emergency department.
McGrath P; Kersten B; Chilbert MR; Rusch C; Nadler M
Am J Emerg Med; 2021 Aug; 46():585-590. PubMed ID: 33257143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
